Gibson Christopher
SEC insider (Form 3/4/5 filer). CIK 0001856369. Director at RECURSION PHARMACEUTICALS, INC. (RXRX) and 1 other issuer. 97 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in MENLO PARK, CA.
Companies Gibson Christopher has filed insider reports for
- RECURSION PHARMACEUTICALS, INC. (RXRX): Director
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB): Director
Gibson Christopher
CIK: 0001856369
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (97 total)
- Jun 5, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
ConversionDirect40K shares- - Jun 5, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect40K shares at avg. $3.62$145K - Jun 3, 2026PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
AwardDirectStock Option (right to buy)
74.5K shares- - May 22, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect40K shares at avg. $3.08$123K - May 22, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
ConversionDirect40K shares- - May 15, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect22.8K shares at avg. $3.04$69K - May 7, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect40K shares at avg. $3.37$135K - May 7, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
ConversionDirect60K shares- - May 7, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
GiftDirect20K shares- - Apr 22, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect40K shares at avg. $3.61$144K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  RXRX RECURSION PHARMACEUTICALS, INC. | Conversion | 40,000 | - | $0 | Direct |
| Jun 5, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 40,000 | $3.62 | $144,800 | Direct |
| Jun 3, 2026 |  PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Award Stock Option (right to buy) | 74,497 | - | - | Direct |
| May 22, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 40,000 | $3.08 | $123,200 | Direct |
| May 22, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Conversion | 40,000 | - | $0 | Direct |
| May 15, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 22,821 | $3.04 | $69,376 | Direct |
| May 7, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 40,000 | $3.37 | $134,800 | Direct |
| May 7, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Conversion | 60,000 | - | $0 | Direct |
| May 7, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Gift | 20,000 | - | $0 | Direct |
| Apr 22, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 40,000 | $3.61 | $144,400 | Direct |
1-10 of 97 transactions